Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis.
Turner MJ, Pang PT, Chretien N, Havari E, LaMorte MJ, Oliver J, Pande N, Masterjohn E, Carter K, Reczek D, Brondyk W, Roberts BL, Kaplan JM, Siders WM.
Turner MJ, et al. Among authors: siders wm.
J Neuroimmunol. 2015 Aug 15;285:4-12. doi: 10.1016/j.jneuroim.2015.05.018. Epub 2015 May 20.
J Neuroimmunol. 2015.
PMID: 26198912
Free article.